- Sponsored Content
- Downstream Processing
BPI Contributor
October 20, 2021
1 Min Read
Sponsored by Cytiva
A critical aspect of therapeutic development and manufacture is host cell protein (HCP) detection, quantitation, and removal from drug substances, to ensure efficacy and prevent immunogenicity.
It is important to mitigate risk by challenging your assay for each new molecule and selecting the most suitable kit.
Cytiva offers a range of solutions to support scientists and developers in creating an effective strategy for HCP control.
Read more about our strategy for HCP control.
About the Author(s)
You May Also Like